HIV and AIDS Trial, Recruiting NCT05887557 Sponsor: University of California, San Francisco Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05887557
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults or teenagers aged 15 or older who are living with HIV
  • People whose most recent HIV test showed the virus is not well controlled (more than 200 copies/mL in the blood), or who have not been taking HIV medication for at least 1 month
  • People who are not currently well connected to HIV medical care — for example, those with no current HIV doctor, no HIV doctor visit in the past 6 months, or at least one missed HIV doctor appointment in the past 6 months
  • People who face at least one major barrier to getting HIV care, such as homelessness or unstable housing, a mental health condition, or use of illegal substances

Who may not be able to join:

  • People who are unable to give informed consent due to a cognitive impairment, a psychotic condition, or being intoxicated at the time of enrollment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katerina Christopoulos, MD, MPH, University of California, San Francisco

Phone: 415-476-4082

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 May 2024
Est. completion
31 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reach; Number of participants with HIV viral suppression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov